GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that three Afirma-related abstracts will be presented at ENDO 2025, the annual meeting of the Endocrine Society, ...

CoPilot reports that 71% of U.S. used car buyers face bait-and-switch pricing, costing consumers $11.8 billion annually.

Roughly 25% of all U.S. THAAD interceptors funded to date were reportedly launched in June, and SM-3s were also expended at a ...